Related Experiment Video

Updated: Feb 17, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K

A case of multiple myeloma presenting with diffuse osteosclerosis and multiple bone infarcts

Marguerite Vignon1, Noémie Senot1, Valérie Bousson2

  • 1Department of Immuno-hematology , Saint-Louis Hospital, AP-HP, 1, avenue Claude-Vellefaux, 75010 Paris, France.

Joint Bone Spine
|December 14, 2017
PubMed
Summary

No abstract available in PubMed .

Keywords:
Bone infarctMultiple myelomaOsteosclerosis

More Related Videos

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.8K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.3K

Related Experiment Videos

Last Updated: Feb 17, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.3K
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.8K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.3K

Related Concept Videos

Bone Disorders01:29

Bone Disorders

5.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.3K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.3K

Articles linked to this work by shared authors, journal, and citation graph.

Stress CMR ischemic burden and long-term mortality in left ventricular systolic dysfunction: a multicenter registry study.

European heart journal. Cardiovascular Imaging·2026

Concomitant Hypertension in Hypertrophic Cardiomyopathy: Clinical Phenotype and Prognostic Associations of Cardiovascular Magnetic Resonance Biomarkers.

European journal of preventive cardiology·2026

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Clinical kidney journal·2026

Long-term Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients with Hypertension without known coronary artery disease.

European heart journal. Cardiovascular Imaging·2026

Five trials reshaping multiple myeloma.

Med (New York, N.Y.)·2026

Prediction of bone marrow fibrosis from complete blood count in myeloproliferative neoplasms (FIBOM-AI): a multicentre machine learning model development and validation study.

The Lancet. Haematology·2026

Association between blood heavy metal concentrations and hyperuricemia: a systematic review and meta-analysis.

Joint bone spine·2026

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: a European cohort study.

Joint bone spine·2026

The influence of symptom duration on flare risk after biologic DMARD withdrawal in axial spondyloarthritis: a meta-analysis of randomized withdrawal trials.

Joint bone spine·2026

Clinical stability despite progressive fatty infiltration in patients over 50 years old with full-thickness rotator cuff tears.

Joint bone spine·2026

Interleukin-33 drives abnormal bone remodeling in ankylosing spondylitis via inhibition of osteoclast differentiation.

Joint bone spine·2026

Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: results from the MAJIK-SFR registry.

Joint bone spine·2026

Boron as a Context-Dependent System-Level Modulator: Mechanisms and Implications in Chronic Diseases.

Biological trace element research·2026

Acetazolamide versus metolazone as adjunctive therapy to loop diuretics in hospitalized patients with volume overload: A retrospective cohort study.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Single-cell and functional profiling identifies an IL6-centered immunometabolic communication circuit in multiple myeloma.

Frontiers in immunology·2026

[Predictive and diagnostic performance of composite anthropometric indicators for obstructive sleep apnea].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2026

Material-bound energy export as a metabolic fate.

Trends in endocrinology and metabolism: TEM·2026

Discovery of novel plasma biomarkers for OATP1B1 activity using nontargeted metabolomics.

Drug metabolism and disposition: the biological fate of chemicals·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us